Login / Signup

Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy.

Wenhui WangYu MenJianyang WangZongmei ZhouDongfu ChenZefen XiaoQinfu FengJima LvJun LiangNan BiShugeng GaoLuhua WangZhouguang Hui
Published in: BMC cancer (2019)
For patients with stage pIII-N2 NSCLC after pneumonectomy and adjuvant chemotherapy, PORT can improve OS, DFS, LRFS and DMFS with tolerable toxicity.
Keyphrases
  • small cell lung cancer
  • early stage
  • patients undergoing
  • oxidative stress
  • radiation therapy
  • locally advanced
  • advanced non small cell lung cancer
  • squamous cell carcinoma
  • brain metastases